FindTrial
Sign In

A 12-month follow up study of probiotic supplementation effects in subjects with autoimmune uveitis.

Status
Recruiting
Phases
Phase 2
Study type
Interventional
Source
EU CTIS
Registry ID
CTIS2024-517946-32-00
Acronym
VFN-MIU-2021-01
Enrollment
9
Registered
2024-12-09
Start date
2023-06-02
Completion date
Unknown
Last updated
2024-12-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Non-infectious uveitis

Brief summary

Time to first disease relapse from the baseline visit (V2)

Detailed description

Severity of first relapse according to the SUN system, Total number of relapses during the study, Changes in BCVA, Changes in OCT parameters

Interventions

DRUGMutaflor

Sponsors

Vseobecna Fakultni Nemocnice V Praze
Lead SponsorOTHER

Eligibility

Sex/Gender
All
Age
18 Years to 64 Years

Design outcomes

Primary

MeasureTime frame
Time to first disease relapse from the baseline visit (V2)—

Secondary

MeasureTime frame
Severity of first relapse according to the SUN system, Total number of relapses during the study, Changes in BCVA, Changes in OCT parameters—

Countries

Czechia

Outcome results

None listed

Source: EU CTIS · Data processed: Feb 4, 2026